Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Panupong Hansrivijit MD

Panupong Hansrivijit MD

Nephrology Fellow, Division of Renal (Kidney) Medicine and Division of Pharmacoepidemiology & Pharmacoeconomics, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts

Dr. Hansrivijit is a third-year nephrology fellow at the combined Brigham and Women's Hospital/Massachusetts General Hospital in Boston, MA. He is also a research fellow at the Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, and a graduating MPH student at the Harvard T.H. Chan School of Public Health. Dr. Hansrivijit has his focus in clinical epidemiology and pharmacoepidemiology of kidney diseases, such as diabetic kidney disease, chronic kidney disease, kidney transplantation, and acute kidney injury.

Disclosures

Dr. Hansrivijit has no relevant disclosures.

Recent Contributions to PracticeUpdate:

  1. Effects of SGLT2 Inhibitors on Cardiovascular and Renal Outcomes in People With Diabetes and Advanced Chronic Kidney Disease

Most Read This Week

Recently Updated